Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Cytokinetics Inc (CYTK) – Cytokinetics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Cytokinetics (CYTK) trades at $75.85, down 3.55% on the day, with strong analyst support showing 94% buy ratings and a $101.50 consensus price target. The stock shows bullish technical momentum with positive moving average signals, while fundamental metrics reflect a pre-revenue biotech profile with significant losses (-$784.96M net income) but promising drug pipeline developments including MYQORZO launch progress and positive Phase 3 trial results for aficamten in non-obstructive HCM.
Investment outlook balances substantial upside potential from successful drug commercialization against high execution risks. The recent $805 million equity offering provides financial runway, but persistent negative cash flow and competitive pressures in cardiac therapeutics require careful monitoring. Wall Street optimism centers on the company's innovative pipeline, though profitability remains several quarters away.
Read full analysis

Key Stats

  • Market Cap
    $10.30B
  • Sector
    Technology
  • 3M Drawdown
    -15.01%
  • Enterprise Value
    $10.77B
  • Dividend Yield
    -
  • Typical Hold Time
    7 days
$75.93
52W Low: $30.28
28 May 2025
52W High: $78.64
14 May 2026

Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $10.30B, with an enterprise value of $10.77B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $30.28 and a high of $78.64, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -15.01%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 7 days, indicating typical investor behavior on the platform.

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.


Technical Indicators
|
|
|
Overall Summary
Bearish (10)Neutral (1)Bullish (16)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $10.30B
  • Sector
    Technology
  • 3M Drawdown
    -15.01%
  • Enterprise Value
    $10.77B
  • Dividend Yield
    -
  • Typical Hold Time
    7 days
$75.93
52W Low: $30.28
28 May 2025
52W High: $78.64
14 May 2026

Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $10.30B, with an enterprise value of $10.77B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $30.28 and a high of $78.64, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -15.01%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 7 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!